These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3969222)

  • 21. Fatal necrotising vasculitis associated with nomifensine.
    Schönhöfer PS; Gröticke J
    Lancet; 1985 Jul; 2(8448):221. PubMed ID: 2862407
    [No Abstract]   [Full Text] [Related]  

  • 22. [Fever and liver function disorders caused by nomifensine (Alival)].
    Dankbaar H; Mudde AH
    Ned Tijdschr Geneeskd; 1980 Dec; 124(51):2184-6. PubMed ID: 7207651
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased sexual function with nomifensine.
    Moore C
    Med J Aust; 1983 Nov; 2(11):538. PubMed ID: 6633379
    [No Abstract]   [Full Text] [Related]  

  • 24. Side effects of Merital (nomifensine).
    Med J Aust; 1983 Mar; 1(6):258. PubMed ID: 6828011
    [No Abstract]   [Full Text] [Related]  

  • 25. Nomifensine-induced immune haemolytic anaemia and impaired renal function.
    Bournerias F; Nabibi B
    Lancet; 1979 Jul; 2(8133):95-6. PubMed ID: 87987
    [No Abstract]   [Full Text] [Related]  

  • 26. Lupus-like syndrome during treatment with nomifensine.
    García-Morteo O; Maldonado-Cocco JA
    Arthritis Rheum; 1983 Jul; 26(7):936. PubMed ID: 6870982
    [No Abstract]   [Full Text] [Related]  

  • 27. Fatal immune haemolysis associated with nomifensine.
    Sokol RJ; Hewitt S; Booker DJ; Stamps R; Taylor M; Stewart RM
    Br Med J (Clin Res Ed); 1985 Aug; 291(6491):311-2. PubMed ID: 3926172
    [No Abstract]   [Full Text] [Related]  

  • 28. Paranoid symptoms after nomifensine.
    Cohen SI
    Lancet; 1982 Oct; 2(8304):928. PubMed ID: 6126770
    [No Abstract]   [Full Text] [Related]  

  • 29. Massive intravascular haemolysis during treatment of nomifensine.
    Lylloff K; Jersild C; Bacher T; Slot O
    Lancet; 1982 Jul; 2(8288):41. PubMed ID: 6123767
    [No Abstract]   [Full Text] [Related]  

  • 30. Paranoid symptoms after nomifensine.
    Katona C
    Lancet; 1982 Aug; 2(8294):384-5. PubMed ID: 6124783
    [No Abstract]   [Full Text] [Related]  

  • 31. [Drug fever caused by the antidepressive agent nomifensine (Alival)].
    Hunziker T; Fehlmann U; Kummer H; Spengler H; Hoigné R
    Schweiz Med Wochenschr; 1980 Sep; 110(36):1295-300. PubMed ID: 7444414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous self-administration of nomifensine in rats: implications for abuse potential in humans.
    Spyraki C; Fibiger HC
    Science; 1981 Jun; 212(4499):1167-8. PubMed ID: 7195072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatic toxicity of new antidepressive drugs. Apropos of a case].
    Zarski JP; Aubert H; Rachail M
    Gastroenterol Clin Biol; 1983 Feb; 7(2):220-1. PubMed ID: 6840468
    [No Abstract]   [Full Text] [Related]  

  • 34. Nomifensine in parkinsonism.
    Teychenne PF; Park DM; Findley LJ; Rose FC; Calne DB
    J Neurol Neurosurg Psychiatry; 1976 Dec; 39(12):1219-21. PubMed ID: 796415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia induced by sulpiride in a patient with hypothyroidism.
    Sandyk R
    Clin Neuropharmacol; 1986; 9(1):100-1. PubMed ID: 3829007
    [No Abstract]   [Full Text] [Related]  

  • 36. Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood.
    Funke HJ; Holtmann W; Ismail S; Jansen W; Leonhardt KF; Muth H; Omer LM; O'Connolly M; Ramm H
    Pharmacopsychiatry; 1986 May; 19(3):120-3. PubMed ID: 3725890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Orofacial dyskinesias associated with lorazepam therapy.
    Sandyk R
    Clin Pharm; 1986 May; 5(5):419-21. PubMed ID: 3720213
    [No Abstract]   [Full Text] [Related]  

  • 38. A clinical pharmacological comparison of diclofensine (Ro 8-4650) with nomifensine and amitriptyline in normal human volunteers.
    Culig J; Ehsanullah RS; Hallett C; Iliopoulou A; Matheson I; Turner P
    Br J Clin Pharmacol; 1983 May; 15(5):537-43. PubMed ID: 6860528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical and neuroendocrine approaches to a malignant syndrome of neuroleptics.
    Ansseau M; Diricq S; Grisar T; Collard J
    Acta Psychiatr Belg; 1980; 80(5):600-6. PubMed ID: 7234452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparison of two iatrogenic dyskinesias.
    Karson CN; Jeste DV; LeWitt PA; Wyatt RJ
    Am J Psychiatry; 1983 Nov; 140(11):1504-6. PubMed ID: 6137963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.